Chartwell Investment Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-8,908
| Closed | -$643K | – | 424 |
|
|
2019
Q4 | $643K | Buy |
8,908
+4,045
| +83% | +$292K | 0.02% | 377 |
|
|
2019
Q3 | $682K | Sell |
4,863
-78
| -2% | -$10.9K | 0.02% | 377 |
|
|
2019
Q2 | $905K | Sell |
4,941
-16,934
| -77% | -$3.1M | 0.03% | 384 |
|
|
2019
Q1 | $3.48M | Buy |
21,875
+384
| +2% | +$61.1K | 0.11% | 252 |
|
|
2018
Q4 | $2.06M | Sell |
21,491
-11,951
| -36% | -$1.14M | 0.07% | 329 |
|
|
2018
Q3 | $4.72M | Buy |
33,442
+8,504
| +34% | +$1.2M | 0.14% | 220 |
|
|
2018
Q2 | $3.9M | Sell |
24,938
-3,495
| -12% | -$547K | 0.12% | 239 |
|
|
2018
Q1 | $4.58M | Sell |
28,433
-370
| -1% | -$59.6K | 0.16% | 201 |
|
|
2017
Q4 | $4.74M | Buy |
28,803
+6,839
| +31% | +$1.13M | 0.16% | 206 |
|
|
2017
Q3 | $1.37M | Sell |
21,964
-19,482
| -47% | -$1.21M | 0.05% | 359 |
|
|
2017
Q2 | $3.3M | Buy |
41,446
+14,575
| +54% | +$1.16M | 0.12% | 225 |
|
|
2017
Q1 | $1.91M | Sell |
26,871
-34,271
| -56% | -$2.44M | 0.07% | 294 |
|
|
2016
Q4 | $3.12M | Buy |
+61,142
| New | +$3.12M | 0.11% | 269 |
|